CTIG News Alert Cti Group [Holdings] Inc (CTIG) 0.3800 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cti Group [Holdings] Inc (CTIG) 0.3800 $CTIG

CTI Group Announces Appointment of Interim President and CEO
GlobeNewswire - Thu Dec 11, 4:33PM CST
via PRWEB - CTI Group (Holdings) Inc. (OTC:CTIG), a global provider of carrier-grade software solutions and services which empower organizations through communication analytics, announced today that Manfred Hanuschek has been named as CTI Group's interim President and Chief Executive Officer, effective immediately upon the retirement of John Birbeck from such positions on December 31, 2014. As previously disclosed, on October 16, 2014, in connection with his retirement, Mr. Birbeck tendered his resignation as President and Chief Executive Officer of the Company, effective December 31, 2014. Mr. Birbeck will continue to serve as a member of CTI Group's Board of Directors. Mr. Hanuschek will retain his duties as CTI Group's Chief Financial Officer.

CTI Group Reports Third Quarter 2014 Results
GlobeNewswire - Fri Nov 14, 3:53PM CST
via PRWEB - CTI Group (Holdings) Inc. (OTCQB:CTIG), a global provider of carrier-grade software solutions and services which empower organizations through communication analytics, reported results for the three and nine months ended September 30, 2014. Revenues for the three and nine months ended September 30, 2014 increased to $4,109,715 and $12,139,253, respectively, as compared to revenues for the three and nine months ended September 30, 2013 of $3,640,209 and $11,409,511, respectively. The increases in revenues was primarily attributable to growth in revenues derived from our SmartRecord(R) product in our Call Accounting Management and Recording ("CAMRA" segment due to an increase in demand for our recording software. The Company reported a net loss for the three months ended September 30, 2014 of $(206,574), or ($0.01) per share, as compared to a net loss of ($292,892), or ($0.01) per share, for the three months ended September 30, 2013. The Company reported net income for the nine months ended September 30, 2014 of $483,383, or $0.02 per share, as compared to a net loss of ($1,196,599), or ($0.04) per share, for the nine months ended September 30, 2013. The net income for the nine months ended September 30, 2014 was primarily attributable to a patent legal settlement with net proceeds of $1,344,749 recognized by the Company.

CTI Group Q2 2014 revenues up YoY
M2 - Mon Aug 18, 5:44AM CDT
CTI Group (Holdings) Inc. (OTC: CTIG) said its revenues for the three and six months ended June 30, 2014 increased to USD4,084,069 and USD8,029,538, respectively, as compared to revenues for the three and six months ended June 30, 2013 of USD3,883,976 and USD7,769,302, respectively.

CTI Group Reports Secord Quarter 2014 Results
GlobeNewswire - Thu Aug 14, 5:09PM CDT
via PRWEB - Revenues for the three and six months ended June 30, 2014 increased to $4,084,069 and $8,029,538, respectively, as compared to revenues for the three and six months ended June 30, 2013 of $3,883,976 and $7,769,302, respectively. The increases in revenues was primarily attributable to growth in revenues derived from our SmartRecord(R) product in our Call Accounting Management and Recording ("CAMRA" segment due to an increase in demand for our recording software. The increase in CAMRA revenues were derived primarily from the operations in the United States which was partially off-set by a decrease in revenue recognized in the United Kingdom in our Electronic Invoice Management ("EIM" segment due to a decrease in demand for professional services. The Company reported net loss for the three months ended June 30, 2014 of $(289,905), or ($0.01) per share, as compared to a net loss of ($351,316), or ($0.01) per share, for the three months ended June 30, 2013. The Company reported net income for the six months ended June 30, 2014 of $689,957, or $0.02 per share, as compared to a net loss of ($903,707), or ($0.03) per share, for the six months ended June 30, 2013. The net income for the six months ended June 30, 2014 was primarily attributable to a patent legal settlement with net proceeds of $1,344,749 recognized by the Company.

CTI Group rejects privatization offer
M2 - Wed Jun 18, 9:16AM CDT
CTI Group Inc. (OTC: CTIG) said that the special committee of CTIG Group's board of directors has rejected the December 30, 2013 proposal of Fairford Holdings Ltd., Michael Reinarts and John Birbeck to purchase all of the outstanding shares of its common stock for USD0.40 per share.

CTI Group's Special Committee of the Board Rejects Privatization Offer
GlobeNewswire - Tue Jun 17, 3:59PM CDT
via PRWEB - CTI Group (Holdings) Inc. (OTCQB:CTIG), a global provider of carrier-grade software solutions and services which empower organizations through communication analytics, reported today that the Special Committee of CTIG Group's Board of Directors, after careful consideration with its legal and financial advisors, rejected the December 30, 2013 proposal of Fairford Holdings Limited, Michael Reinarts and John Birbeck to purchase all of the outstanding shares of common stock of CTI Group for a cash purchase price of $0.40 per share.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 95

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 133

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 91

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 68

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 61

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Chicago Kertész Show Puts Photography's Quiet Giant First

Updated Category News Views 112

A fork, a plate, and a sharp eye can outlast plenty of louder art. Leica Gallery Chicago is putting that proposition on the wall with André Kertész: The Master, opening December 4, 2026 and running through January 17, 2027. More than thirty signature works is not a sprawling museum survey, and frankly that may be the point. Kertész did not need grand scale to make his...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 44

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 110

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading

Top 5 Most Recently Viewed Articles

Epic Yoga Event by Real Essentials to Support Ovarian Cancer

Updated Category News Views 70

Real Essentials Teams Up for Ovarian Cancer Awareness To honor Ovarian Cancer Awareness Month, Real Essentials, a brand celebrated for its affordable yet high-quality apparel, partnered with Not These Ovaries, a nonprofit organization dedicated to ovarian cancer. Together, they created a unique yoga event that aimed to raise both awareness and funds for essential ovarian...

Continue Reading
MKDWELL Tech Inc. Posts H1 2024 Financial Results Drop

Updated Category News Views 115

MKDWELL Tech Inc. Financial Overview for 2024 MKDWELL Tech Inc. (NASDAQ: MKDW), a key player in the automotive electronics industry with operations in Mainland China and Taiwan, has provided an update on its financial status for the first half of the fiscal year. The latest results show a significant decline in revenue compared to the same period in the previous year....

Continue Reading
Northwest Pipe Company Strengthens Production with New Facility

Updated Category News Views 212

Northwest Pipe Company Enhances Production Capacity Northwest Pipe Company, renowned for its expertise in water-related infrastructure, has announced a significant upgrade to its production facilities. The company has recently inaugurated a new precast concrete pipe and manhole manufacturing plant aimed at addressing the rising demand in the region. With this strategic...

Continue Reading
Allient Inc. Posts Third Quarter Gains Driven by Initiatives

Updated Category News Views 99

Allient Inc. Announces Impressive Third Quarter Results Allient Inc. (NASDAQ: ALNT), a global leader in precision and specialty Motion, Controls and Power products, has announced significant financial results for its third quarter. Despite facing challenges in key industrial and vehicle markets, the company has demonstrated resilience through its operational improvements...

Continue Reading
Fulcrum Therapeutics Investor Event to Unveil PIONEER Findings

Updated Category News Views 191

Introduction to Fulcrum Therapeutics Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a pioneering biopharmaceutical company, is dedicated to enhancing the lives of individuals grappling with genetically defined rare diseases. Their primary focus is on developing innovative small molecules that target specific diseases at their root cause. This commitment drives their latest...

Continue Reading